BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jia JW, Li KL, Wu JX, Guo SL. Clinical significance of annexin II expression in human non-small cell lung cancer. Tumour Biol. 2013;34:1767-1771. [PMID: 23494179 DOI: 10.1007/s13277-013-0715-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Gao KM, Chen XC, Zhang JX, Wang Y, Yan W, You YP. A pseudogene-signature in glioma predicts survival. J Exp Clin Cancer Res 2015;34:23. [PMID: 25880120 DOI: 10.1186/s13046-015-0137-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
2 Sharma MC. Annexin A2: An emerging biomarker and potential therapeutic target for aggressive cancers. Int J Cancer. 2019;144:2074-2081. [PMID: 30125343 DOI: 10.1002/ijc.31817] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
3 Zhao Z, Lu L, Li W. TAGLN2 promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of colorectal cancer cells by activating STAT3 signaling through ANXA2. Oncol Lett 2021;22:737. [PMID: 34466149 DOI: 10.3892/ol.2021.12998] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang CY, Lin CF. Annexin A2: its molecular regulation and cellular expression in cancer development. Dis Markers. 2014;2014:308976. [PMID: 24591759 DOI: 10.1155/2014/308976] [Cited by in Crossref: 42] [Cited by in F6Publishing: 62] [Article Influence: 6.0] [Reference Citation Analysis]
5 He H, Xiao L, Cheng S, Yang Q, Li J, Hou Y, Song F, Su X, Jin H, Liu Z, Dong J, Zuo R, Song X, Wang Y, Zhang K, Duan W, Hou Y. Annexin A2 Enhances the Progression of Colorectal Cancer and Hepatocarcinoma via Cytoskeleton Structural Rearrangements. Microsc Microanal. 2019;25:950-960. [PMID: 31172894 DOI: 10.1017/s1431927619000679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Beyene DA, Kanarek NF, Naab TJ, Ricks-Santi LL, Hudson TS. Annexin 2 protein expression is associated with breast cancer subtypes in African American women. Heliyon 2020;6:e03241. [PMID: 32072035 DOI: 10.1016/j.heliyon.2020.e03241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang H, Yao M, Wu W, Qiu L, Sai W, Yang J, Zheng W, Huang J, Yao D. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma. Tumour Biol. 2015;36:9373-9383. [PMID: 26109000 DOI: 10.1007/s13277-015-3678-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
8 Xu C, Sheng Z, Hu H, Hao K, Wang Q, Yu L. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer. Tumor Biol 2014;35:8673-8. [DOI: 10.1007/s13277-014-2039-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
9 Yang HP, Fan SJ, An Y, Wang X, Pan Y, Xiaokaiti Y, Duan JH, Li X, Tie L, Ye M. Bisdemethoxycurcumin exerts pro-apoptotic effects in human pancreatic adenocarcinoma cells through mitochondrial dysfunction and a GRP78-dependent pathway. Oncotarget. 2016;7:83641-83656. [PMID: 27845899 DOI: 10.18632/oncotarget.13272] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
10 Choi CH, Chung JY, Chung EJ, Sears JD, Lee JW, Bae DS, Hewitt SM. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer. BMC Cancer 2016;16:448. [PMID: 27402115 DOI: 10.1186/s12885-016-2459-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
11 Wang Y, Deng J, Guo G, Tong A, Peng X, Chen H, Xu J, Liu Y, You C, Zhou L. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma. J Neurooncol 2017;131:21-9. [DOI: 10.1007/s11060-016-2273-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
12 Cohen-inbar O, Zaaroor M. Glioblastoma multiforme targeted therapy: The Chlorotoxin story. Journal of Clinical Neuroscience 2016;33:52-8. [DOI: 10.1016/j.jocn.2016.04.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
13 Lokman NA, Pyragius CE, Ruszkiewicz A, Oehler MK, Ricciardelli C. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome. Transl Res 2016;171:83-95.e1-2. [PMID: 26925708 DOI: 10.1016/j.trsl.2016.02.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
14 Wang L. Screening and Biosensor-Based Approaches for Lung Cancer Detection. Sensors (Basel) 2017;17:E2420. [PMID: 29065541 DOI: 10.3390/s17102420] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
15 Han F, Shrestha S, Huang H, Lv HY, Nie C, Lin L, Lu ML. Expression of annexin II in gastric carcinoma and its role in gastric cancer metastasis. World J Gastroenterol 2017; 23(38): 7009-7015 [PMID: 29097873 DOI: 10.3748/wjg.v23.i38.7009] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
16 Ojeda PG, Wang CK, Craik DJ. Chlorotoxin: Structure, activity, and potential uses in cancer therapy: Chlorotoxin. Biopolymers 2016;106:25-36. [DOI: 10.1002/bip.22748] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 8.6] [Reference Citation Analysis]